Wow. Next phase larger scale study now inevitable with 1 of 17 untreatable cancers progressing on the half dose of NOX66 and 1 of 5 on the full dose showing > 30% lesion shrinkage. 5 more patients completing over the next quareter for the full results to be published and phase 2 to come to town.
Ann: Promising Interim Clinical Data for NOX66, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.3¢ |
Change
-0.012(11.4%) |
Mkt cap ! $27.17M | |||
| Open | High | Low | Value | Volume |
| 10.3¢ | 10.5¢ | 9.0¢ | $59.97K | 617.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32000 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 82221 | 2 |
View Market Depth
| Last trade - 15.59pm 29/08/2024 (20 minute delay) ? |
| NOX (ASX) Chart |